Company News

Welcome to the Company News room where you can find the latest regulatory news and press releases from our parent company, Open Orphan plc.

07.09.20 hVIVO present at 2020 ERS International Congress
10.08.20 Major New Contract Win with Top 3 Pharma Company
04.08.20 New Contract Win with Carna Bioscience (“Carna”)
28.07.20 Contract for COVID-19 Vaccine Trial
15.07.20 Option to Acquire CHIMagents Limited
07.07.20 Additional Laboratory Services Contracts Signed
24.06.20 Results for the year ended 31 December 2019
15.06.20 Positive Phase I results published in The Lancet
11.06.20 Major New Contract Signed
04.06.20 Press Launch of hVIVO COVID Clear Test
22.05.20 Results of Fundraising
22.05.20 Proposed Fundraising to raise up to £12 million
22.05.20 PrimaryBid.com Offer
18.05.20 Update on antibody test and share price movement
11.05.20 New COVID-19 Antibody Testing Partnership
04.05.20 Major New Contract and Directorate Change
23.04.20 Testing of anti-viral for treating COVID-19
16.03.20 Publication of positive results in journal
10.03.20 Publication of Positive Results in Journal
09.03.20 Coronavirus Challenge Study Model
09.03.20 Completion of Compulsory Acquisition of Shares
06.03.20 New Contract
27.02.20 Appointment of new Director
26.02.20 Result of Rule 15 Offer and Total Voting Rights
20.02.20 Appointment of Chair of Advisory Board
31.01.20 Results of Placing and Subscription
31.01.20 Proposed Placing to raise a minimum of £5 million
28.01.20 Compulsory Acquisition of Remaining hVIVO Shares
23.01.20 Update on Placing
20.01.20 Completion of Merger with hVIVO and ReAdmission
17.01.20 Offer Wholly Unconditional
14.01.20 Second Closing of the Offer